Presentation
7 March 2022 Cutaneous pharmacokinetics of escalating Ruxolitinib formulation doses utilizing a coherent Raman imaging pipeline
Author Affiliations +
Abstract
Systemic drug delivery for dermatological conditions yields little drug to the intended site of action resulting in adverse effects. Topical drug delivery is a viable alternative yet the local cutaneous pharmacokinetics (cPK) is relatively under-explored. Product dosing is dependent upon the knowledge of the dose-cPK relationship, which coincides with the pharmacodynamic (PD) activity. Coherent Raman imaging (CRI) can quantify tissue-specific drug localization and elucidate micro-scale cPK estimates, affording a clinically relevant cPK-PD relationship. This demonstration of a dose-cPK relationship utilizing CRI offers a stepping stone for additional formulation evaluation ex vivo.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Benjamin Kuzma, Thomas Würthwein, Nick Lemberger, Kristin Wallmeier, Carsten Fallnich, Conor L. Evans, Kim Troensegaard Nielsen, Louise Bastholm Jensen, Lars Svensson, and Jean-Luc Tran "Cutaneous pharmacokinetics of escalating Ruxolitinib formulation doses utilizing a coherent Raman imaging pipeline", Proc. SPIE PC11938, Visualizing and Quantifying Drug Distribution in Tissue VI, PC1193808 (7 March 2022); https://doi.org/10.1117/12.2608845
Advertisement
Advertisement
KEYWORDS
Coherence imaging

Raman spectroscopy

Ear

Tissues

Skin

Back to Top